Regulatory Compliance

Manassas, Va. and Wichita, Kan. – September 18, 2026 -- Electra and The Atlas Group have signed an airframe manufacturing agreement for the EL9 Ultra Short aircraft, with Atlas set to build and assemble airframes for Electra's flight test and certification program starting this month.

Atlas begins airframe production this month with first deliveries targeted for 2027

Work commences at Atlas facilities immediately, feeding Electra's certification campaign for the nine-passenger hybrid-electric EL9, which is designed to take off and land in as little as 150 feet. The two companies will jointly mature production architecture and reduce manufacturing risk ahead of scaled output.

"Realizing this vision requires more than a breakthrough aircraft; it requires the ability to build and deliver it with the consistency and scale of an advanced production system," said Marc Allen, CEO of Electra.

Ottawa, ON -- Claigan Environmental will run two identical webinars on September 18, 2026, to help manufacturers budget for restricted materials compliance requirements taking effect in 2027.

Two sessions scheduled same day due to expected demand

Claigan will hold back-to-back one-hour sessions at 10am and 2pm on September 23, each including a question-and-answer segment. The company cited anticipated demand as the reason for scheduling duplicate webinars rather than a single event.

Redwood City, Calif. – September 18, 2026 -- The Secure Access Service Edge (SASE) market reached $3.5 billion in the second quarter of 2026, extending year-over-year growth above 20 percent for a fifth consecutive quarter, according to Dell'Oro Group.

SD-WAN spending strengthens as enterprises replace aging branch infrastructure

SD-WAN demand rose materially in Q2 as branch-network modernization climbed enterprise priority lists. Dell'Oro Group found the trend reflects selective replacement of aging or higher-risk equipment rather than a wholesale refresh across entire branch estates.

Westminster, Colo. – – September 18, 2026 -- The Weed Science Society of America (WSSA) has formalized deeper ties with the Aquatic Plant Management Society (APMS) after the two groups' shared leadership produced measurable research and policy gains at APMS's 66th Annual Meeting in Phoenix, Arizona, held July 13-16.

APMS honors WSSA scientists for research and publishing milestones

Ramon Leon, Ph.D., of NC State University received the APMS T. Wayne Miller Distinguished Service Award for converting the Journal of Aquatic Plant Management from a print-only format to open-access digital publication. Chris Mudge, Ph.D., of the U.S. Army Corps of Engineers won the society's top honor, the Outstanding Research Contributor award, for advancing aquatic plant management to protect U.S. water resources.

Pinehurst, N.C. – September 18, 2026 -- MedicareCompliance.com launched an independent industry platform designed to connect carriers, agencies, third-party marketing organizations and compliance professionals navigating Medicare's regulatory environment. The platform, a division of EnrollHere Inc. operating independently, opened its Medicare Compliance Community to members seeking industry intelligence, regulatory discussions and networking access.

Inaugural industry event scheduled for Washington, D.C. in January 2027

MedicareCompliance.com confirmed its first industry event will run Jan. 20-21, 2027, in Washington, D.C., convening ecosystem leaders on regulatory, technological and operational issues. Community members will receive details on speakers and programming as they are finalized.

Dallas – September 18, 2026 -- Nanoscope Therapeutics will unveil four-year follow-up data showing sustained visual acuity gains from its gene therapy MOGENRY® in retinitis pigmentosa patients, with the FDA already having accepted and filed the company's Biologics License Application.

Christine Kay to present long-term durability data at Retina Society meeting

Dr. Christine Kay, Director of Clinical Research and Retinal Genetics at Vitreoretinal Associates in Gainesville, will present the data on September 23, 2026, at the 59th Annual Scientific Meeting of the Retina Society in Los Angeles. The presentation, titled "Lasting Vision Improvement With MCO-010 Optogenetic Therapy," draws on the REMAIN 4-year extension of the RESTORE Phase 2b/3 trial (NCT04945772) and is scheduled for 3:15 PM PT at the Fairmont Century Plaza Hotel.

Casper, Wyoming – September 18, 2026 -- DISA Uranium Corporation has agreed to acquire a portfolio of uranium and vanadium projects in Colorado's Uravan Mineral Belt from Premier American Uranium Inc. (TSXV: PUR) (OTCQB: PAUIF) and will simultaneously invest US$5 million in the company, marking its second major U.S. uranium consolidation move this year.

Pinellas Park, Fla. – September 18, 2026 -- Brundage Group has appointed Des Varady as president, tapping a 30-year health care and technology executive to oversee operations as the clinical compliance and revenue integrity firm scales nationally.

Varady brings three decades of leadership in physician-centric health care businesses

Varady previously served as chief executive officer of Corridor, where he built the company into a leader in revenue cycle and education solutions for post-acute care providers. He also held CEO roles at Radsource, a provider of physician radiology services, and HWT, a health care data services firm.

Milwaukee – September 18, 2026 -- The Doula Alliance of Arkansas (DA-AR) has secured $860,500 through Arkansas' Rural Health Transformation Program (RHTP) to place ten certified community-based doulas inside rural clinic care teams, using a coordination platform built by MySwaddle, a maternal health technology company developed by Holista.

Stockholm – September 18, 2026 -- SciBase Holding AB has pushed back the first day of trading in subscription rights and paid subscribed shares (BTA) tied to its ongoing rights issue by one day, moving the start date from September 18, 2026 to September 18, 2026 on Nasdaq First North Growth Market.

The subscription period itself remains unchanged, running from September 15 through September 18, 2026.

Timetable shift leaves subscription window intact

The Swedish medtech company confirmed the updated timetable applies only to the trading commencement of subscription rights and BTAs, not to the underlying subscription mechanics of the capital raise.

Michael Colérus, Chief Financial Officer of SciBase, is the designated contact for investor inquiries related to the adjustment.